Sab Biotherapeutics, Inc.
SABS
Revenue
263.14k
▼-681.44k▼-72.14%
3 Months ChangeAssets
44.20M
▼-9.60M▼-17.85%
3 Months ChangeLiabilities
18.23M
▲1.33M▲7.88%
3 Months ChangeFree Cash Flow
-10.88M
▼-9.25M▼-568.65%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-09
Form 8-K
ID: 0000950170-24-104564
2024-08-08
Form 10-Q
ID: 0000950170-24-094084
2024-07-31
Form 8-K
ID: 0000950170-24-088247
2024-06-27
Form 8-K
ID: 0000950170-24-078622
2024-05-31
Form 8-K
ID: 0000950170-24-066856
2024-05-21
Form 8-K
ID: 0000950170-24-062656
2024-05-20
Form 10-Q
ID: 0000950170-24-062367
2024-05-08
Form 8-K
ID: 0000950170-24-054868
2024-04-15
Form 8-K
ID: 0000950170-24-044497
2024-03-29
Form 8-K
ID: 0000950170-24-038429